BioGaia AB Interim report 1 January - 30 September 2008
BioGaia AB Interim Report 1 January - 30 September 2008
(Figures in brackets refer to the same period of last year)
Key events in the third quarter of 2008
Key events after the end of the third quarter
"Our long-term focus on research and product development has given us unique products with very positive clinical results. That there is a demand for these products in the market is visible in our robust sales growth with healthy gross margins and net margins of around 20%. We are not noticing any negative effects of the financial crisis or market downturn, as our products are sold primarily via pharmacies and belong to a segment that is generally not as cycle-sensitive as many others. We therefore look forward to continued strong growth.
The company has a very solid financial position with no loans, net cash of SEK 59 million and an equity/assets ratio of 87 %", says Managing Director Peter Rothschild.
Latest press releases from BioGaia:
2008-10-08 BioGaia invests in LifeTop Cap in new subsidiary
2008-09-17 Nestlé launches "Boost Kid Essentials" in the US with BioGaia's Probiotic straw
2008-09-08 Q-Mejerierna launches yoghurt drink with BioGaia's probiotic
For additional information contact Peter Rothschild, Managing Director, telephone: +46 8 -555 293 00
Jan Annwall, Deputy Managing Director, telephone: +46 8 - 555 293 00
BioGaia is a biotechnology company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Small Cap list of the Nasdaq OMX Nordic Exchange Stockholm.